Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
OpenAI unveils GPT-5.6 AI models with phased rollout and stronger safety checksOpenAI has unveiled GPT-5.6, its latest AI model family with Sol, Terra and Luna. The models will roll out gradually across ChatGPT, the AP...
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
DU UG Admissions 2026: CSAS Phase 1 registration begins; Direct link, eligibility, how to apply & complete admission processDU UG Admissions 2026: Delhi University has launched the first phase of undergraduate admissions for 2026-27 via the CSAS portal. Aspiring ...
Pharmeasy founders’ new venture All Home raises Rs 200 crore; valuation doublesAll Home, which operates in the interior design and architecture space, partners with brands by investing in them and providing capabilitie...
India at risk of AI blackout? Why Bernstein wants India to have its own DeepSeekBernstein has warned that India risks an "AI blackout" if it remains dependent on foreign AI models, urging the country to develop its own ...
India among top AI-ready nations, one of world's least concentrated equity markets: J.P. MorganIndia has emerged as one of the top countries in artificial intelligence (AI) readiness, trailing only the U.S. and China, while remaining ...
US remains global leader in AI, but China rapidly closing gap with cheaper models: JP MorganThe United States stands at the forefront of AI development, yet China is swiftly closing the gap with cost-efficient AI systems. Chinese c...
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
Claude down again? Users report errors as Anthropic confirms “elevated error rate” and investigates service disruption. Here's what users can do if Claude is not workingClaude down: AI chatbot Claude is experiencing widespread service disruptions today, June 23, 2026, with users reporting errors and failed ...
Is Sakana Fugu really better than Anthropic's Fable 5 and Mythos preview?Japanese artificial intelligence (AI) startup Sakana AI has launched its multiagent orchestration system Sakana Fugu, claiming it outperfor...
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
Ten days after Fable 5 shutdown, Sakana AI makes its moveA Japanese AI lab, Sakana AI, has launched Fugu and Fugu Ultra, innovative AI systems that claim frontier-level capabilities without relyin...
Kunal Shah heads to Meta; New-age IPO playbookHappy Tuesday! Kunal Shah has taken over as WhatsApp's chief, while Meta backs Cred in a major funding deal. This and more in today’s ETtec...
Filing pension complaints gets easier as PFRDA rolls out AI-enabled Pension Sahayak: Key features explainedPFRDA has launched Pension Sahayak, an AI-powered platform simplifying pension grievance redressal. This upgrade from the old CGMS offers w...
Claude down worldwide? Check the reason behind the latest outage affecting users across the globeClaude AI users worldwide are experiencing a second major service disruption this month, with many reporting failed requests and login issu...
API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...